Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 0.21
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Biotechnologies Assets SA develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is neutral on EV/EBITDA, underpriced on P/FC.
Data is available to registered users only
Buy
Sell